AntihyperglycaemicsBullous pemphigoid: 9 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2018年 / 1694卷 / 1期

关键词：

D O I：

10.1007/s40278-018-43436-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：34 / 34

相关论文

共 50 条

[41] Ipilimumab/Nivolumab/PembrolizumabBullous pemphigoid: 7 case reports
Reactions Weekly, 2025, 2050 (1) : 286 - 286
[42] DupilumabBullous-pemphigoid flare : 2 case reports
Reactions Weekly, 2020, 1822 (1) : 124 - 124
[43] Linagliptin/sitagliptin/vildagliptinBullous pemphigoid: 13 case reports
Reactions Weekly, 2020, 1801 (1) : 171 - 171
[44] PalbociclibBullous pemphigoid and erythema multiforme: 2 case reports
Reactions Weekly, 2021, 1845 (1) : 313 - 313
[45] Ipilimumab/methotrexate/pembrolizumabBullous pemphigoid: 2 case reports
Reactions Weekly, 2016, 1617 (1) : 143 - 143
[46] Linagliptin/sitagliptin/vildagliptinBullous pemphigoid: 5 case reports
Reactions Weekly, 2021, 1851 (1) : 210 - 210
[47] Sitagliptin/vildagliptin/metforminBullous pemphigoid: 3 case reports
Reactions Weekly, 2013, 1448 (1) : 28 - 28
[48] Penpulimab/sintilimab/toripalimabBullous pemphigoid: 3 case reports
Reactions Weekly, 2022, 1918 (1) : 413 - 414
[49] Multiple drugsBullous pemphigoid, drug dependence and lack of efficacy in bullous pemphigoid : 2 case reports
Reactions Weekly, 2020, 1817 (1) : 219 - 219
[50] Naphazoline/nivolumabOcular mucus membrane pemphigoid: 2 case reports
Reactions Weekly, 2023, 1970 (1) : 221 - 221

← 1 2 3 4 5 →